In focus
Latest feed
Samsung Biologics Strikes $1.8 Billion Deal for Swiss Peptide Maker PolyPeptide Group
The Unseen Engine of Medicine: Small Molecule API Market Poised for Explosive Growth
Dixon Technologies: Navigating the Headwinds of Rising Costs and Shifting Markets
Indian Pharma Eyes Major Gains as US BIOSECURE Act Targets Chinese Biotech
